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Functional Biomaterials Modulate 
Macrophage in the Tumour 
Micro-environment
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Abstract
The inflammation response requires the cooperation of macrophages with 
immune cell function and active factors, such as cytokines and chemokines. 
Through this response, these factors are involved in the immune response to affect 
physiological activities. Macrophages can be categorized into two types: ‘M1’ and 
‘M2’. M1 macrophages destroy the pathogen through phagocytosis activation, ROS 
production, and antigen-presenting, among other functions. M2 macrophages 
release cellular factors for tissue recovery, growth, and angiogenesis. Studies have 
determined that tumour tissue presents with numerous macrophages, termed 
tumour-associated macrophages. Tumour cells and peripheral stromal cells stimu-
late the tumour associated with macrophages (M2) to produce factors that regulate 
angiogenesis. Modulating the balance of the M1 and M2 function has already gained 
interest as a potentially valuable immune disease therapy. However, applications 
of the immunotherapy in clinical treatments are still not clear with regard to the 
cellular working mechanism. Therefore, we summarized the functions of common 
biomaterials involved in the modulation of the macrophage.
Keywords: macrophage, polarization, tumour micro-environment, biomaterials, 
cytokines
1. Introduction
Inflammation has been demonstrated to be a critical factor in the induction of 
immune disease. Immunotherapy is a novel therapeutic approach for anti-inflam-
mation, which could help avoid drug resistance. However, findings have indicated 
that the balance of inflammation and anti-inflammation is crucial. Cellular ROS 
are produced by stress to clear pathogen infections [1]. The inflammatory response 
involves macrophages, dendritic cells, and M cells, which are crucial protectors. 
These cells present partial antigens to enhance the T-cell activation and cytokine 
production, which modulate the host micro-environment. Cytokines are produced 
and released as signals to regulate the immune cell function.
Immunotherapy was developed as an approach to rectify the imbalanced inflam-
mation. Immunotherapy was hypothesized as a possible alternative therapy applied 
in the early phase of clinical therapy and immunomodulation in the early stages 
of immune disease. The common immunotherapy employs natural functional 
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materials including triterpenoids and polysaccharides. Studies have demonstrated 
that functional polysaccharides can promote macrophage differentiation into M1 
or M2, and the ratio modulates the host micro-environment through cytokine 
secretion.
Polysaccharides such as beta-glucan are considered to be biological response 
modifiers (BRMs) that activate macrophages and modulate the inflammation 
response. Findings have indicated that beta-glucan combines with receptors 
expressed on the macrophage cell surface, such as Toll-like receptor. Once com-
bined, alveolar macrophages, Kupffer cells, Langerhans cells, mesangial cells, and 
microglial are activated through toll-like receptor 4–mediated signalling pathways 
to modulate the immune response.
2. Macrophage activation
Macrophages are present in almost all tissues and coordinate developmental, 
metabolic, and immunological functions, thereby contributing to the maintenance 
of homeostasis. Macrophages have a complex role in tissues and act on lipopolysac-
charide (LPS), interferon-γ (IFN-γ), and interleukin (IL)-4 to polarize the M0 into 
M1. Macrophages are activated by exposure to various stimuli. The stimuli that act 
on macrophages are categorized into danger, homeostatic, metabolic, and modula-
tory signals. Danger signals include pathogen-associated molecular patterns, such 
as LPS. Tissue macrophage exposure to danger signals results in an inflammatory 
response. Findings have indicated that tumour environments contain numerous 
transmitters, such as M-CSF, IL-6, IL-10, TGF-β, and COX-2, which induce tumour 
megakaryocytes to differentiate into M2 macrophages, which, in addition to having 
poorer antigen-presenting and cytotoxic abilities, also secrete factors that inhibit 
immune cells, resulting in an enhanced immune inhibitory effect of the tumour 
environment as shown in Figure 1. We investigated the modulation of M1 and M2 in 
the tumour environment by using immunomodulators to delay or inhibit the tumour 
to identify alternative approaches to reduce the side effect of tumour chemotherapy. 
Inflammation is a crucial adaptive response for animals, and the mechanism involves 
a complex interaction of molecular mediators. The functions of immune cells in a 
micro-environment are mediated by responses that occur at all levels of biologi-
cal organization [2]. This process involves cooperation among cells and media-
tors, and the classical immune response varies based on a wide range of factors, 
including the stage of the inflammation process, the tissue or organ involved, and 
whether the inflammation is acute and resolving or chronic and nonresolving [3]. 
The inflammation process involves vascular permeabilization, active migration of 
blood cells, and passage of plasma constituents into injurious tissue [4]. Studies 
have demonstrated that the infiltration of immune cells during the inflammation 
process plays a crucial role in atherosclerosis [5]. Blood leukocytes are mediators of 
host defences and inflammation localized in the earliest lesions of atherosclerosis 
in experimental animals. The study of inflammation in atherosclerosis provided 
new insights into the mechanisms underlying the recruitment of leukocytes [6]. 
Recently, studies have indicated that inflammation plays a role in Alzheimer disease 
(AD) [7]. Inflammatory components involved in AD neuroinflammation include 
brain cells (such as microglia and astrocytes), the complement system, and cyto-
kines and chemokines [8]. Regarding cancer development [9], proinflammatory 
cytokines, including chemokines; matrix metallopeptidase (MMP)-9; vascular 
endothelial growth factor (VEGF); and IL-1α, IL-1β, IL-6, IL-8, and IL-18, are 
primarily regulated by the transcription factor nuclear factor (NF)-kB, which is 
active in most tumours and is induced by carcinogens [10]. Cutaneous wound repair 
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is a tightly regulated and dynamic process involving blood clotting, inflammation, 
new tissue formation, and tissue remodeling [11]. Thrombin is the protease involved 
in blood coagulation. Thrombin deregulation can lead to haemostatic abnormalities, 
which range from subtle subclinical to life-threatening coagulopathies (i.e., during 
septicaemia) [12]. Inflammation and blood coagulation is part of the innate host 
protection mechanism against vascular injury, infection, or other wounds. Cells 
of the innate immune system, endothelial cells, and platelets are actively involved 
in acute and chronic inflammation; they release proinflammatory mediators and 
recruit leukocytes [13]. The protease-activated receptor (PAR) family serves as 
sensor of serine proteinases in the blood clotting system in the target cells involved 
in inflammation. Activation of PAR-1 by thrombin and of PAR-2 by factor leads to 
a rapid expression and exposure of both adhesive proteins that mediate an acute 
inflammatory reaction and of the tissue factor that initiates the blood coagulation 
cascade on the membrane of endothelial cells [14]. In this process, cooperation 
among cells and mediators occurs, and a wide range of factors are involved in the 
classical immune response: (1) the stage of the inflammation process; (2) the tissue or 
organ involved; and (3) whether the inflammation is acute and resolving or chronic 
and nonresolving [15]. The inflammation process involves vascular permeability, 
active migration of blood cells, and the passage of plasma constituents into injurious 
tissue [4]. Studies on the infiltration of immune cells have demonstrated that the 
inflammation process plays a crucial role in atherosclerosiss [5]. Blood leukocytes, 
mediators of host defences and inflammation, localize in the earliest lesions of athero-
sclerosis in experimental animals. The study of inflammation in atherosclerosis has 
provided numerous new insights into the mechanisms underlying the recruitment 
of leukocytes [6]. Studies have reported that inflammation is involved in Alzheimer’s 
disease (AD) [7]. Inflammatory components involved in AD neuroinflammation 
include brain cells (such as microglia and astrocytes), the complement system, and 
Figure 1. 
Macrophages can be categorized into two types: ‘M1’ and ‘M2’. M1 macrophages destroy the pathogen through 
phagocytosis activation, ROS production, and antigen-presenting, among other functions. M2 macrophages 
release cellular factors for tissue recovery, growth, and angiogenesis. We thought that the regulation of 
macrophage is beneficial to reduce the auto-immune disease.
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cytokines and chemokines [8]. Regarding cancer development, proinflammatory 
cytokines, including chemokines, MMP-9, VEGF, and IL-1α, IL-1β, IL-6, IL-8, and 
IL-18, are primarily regulated by the transcription factor NF-kB, which is active in 
most tumours and is induced by carcinogens [9, 10]. Macrophages play a crucial 
role in inflammation process, tumour growth, and tumour progression by induced 
angiogenesis. Studies have reported that promotion of angiogenesis with the produc-
tion of proangiogenic factors, such as TGFβ, VEGF, PDGF, members of the fibro-
blast growth factors family, and angiogenic chemokines [16], and the development 
of breast cancer and several other human tumours was correlated with macrophage 
infiltration [17]. VEGF-C production by tumour-associated macrophages (TAMs) 
was reportedly involved in peritumoral lymphangiogenesis and the subsequent 
dissemination of cancer cells with formation of lymphatic metastasis [18]; moreover, 
macrophage colony-stimulating factor (M-CSF) and VEGF actively recruit circulat-
ing blood monocytes at the tumour site [19].
3. Polysaccharide function on the immunomodulation
Evidence has indicated that acetyl-xylogalactan extracted from Sarcodia suieae 
induced macrophage polarization through the IL-1β, TNF, and Malt-1 expression 
[20]. Nakanishi et al determined that celecoxib can alter the immune inhibitory 
effects of the tumour micro-environment by promoting the transformation of TAMs 
into M1 macrophages, leading to inhibited tumour growth [21]. In 1968, Ikekawa 
et al. reported that the fruiting body extracts from Lentinus edodes, Trametes versi-
color, Ganoderma tsugae, Flammulina velutiper, and Tricholoma matsutake demon-
strated significant antitumour activities in transplanted Sarcoma 180 tumour cells 
[22, 23]. Studies have reported that Antrodia camphorata-derived beta-glucan dem-
onstrated inhibitory effects on tumour growth in Sarcoma 37, Sarcoma 180, Erlich 
ascites sarcoma, Yoshida sarcoma, and LLC1 transplanted tumour [24]. Daily intake 
of A. comphorata-derived beta-glucan for 18 consecutive days was demonstrated to 
slow tumour growth and reduce the rate of metastasis [25]. Cytotoxic T-cell activity 
and tumour occurrence rate were investigated and the results revealed that daily oral 
intake of Grifola frondosa-derived beta-glucan or Lentinan can enhance cytotoxic 
T-cell activity and reduce tumour occurrence rate [26]. Furthermore, the addition 
of conditioned medium with tumour cells into the progenitors of dendritic cells 
was determined to further inhibit the maturation of dendritic cells and lower the 
antigen-presenting capability of the dendritic cells [27]. Studies have reported that 
tumour cells secrete M-CSF, thereby inhibiting dendritic and T-cell differentiation 
and antitumour ability [27–30]. In the tumour environment, the amounts of M1 and 
M2 macrophages are not equal [31]. Tumour environments are known to contain a 
large number of transmitters such as M-CSF, IL-6, IL-10, TGF-β, and COX-2, which 
induce tumour megakaryocytes to differentiate into M2 macrophages, which have 
poorer antigen-presenting and cytotoxic abilities and secrete factors that inhibit 
immune cells, resulting in an enhanced immune inhibitory effect of the tumour 
environment [16, 32–41]. M2 macrophages in tumour-bearing mice enhance tumour 
growth and immune inhibitory effects. M2 macrophages also secrete cytokines, such 
as IL-10 and TGF-β, in high quantities, which attract noncytotoxic Treg-cells and 
Type 2 helper T cells to congregate in tumour tissues, which in turn inhibit the dif-
ferentiation and normal functions of T cells, including their cytotoxic ability, which 
further leads to T-cell apoptosis [38, 40, 42–44]. The Th1 and Th2 polarization is 
built on cytokine patterns, which begin when the antigen-presenting cells interact 
with the naive T cells and polarize into type 1 and type 2 cells in response to the 
type of antigen encountered [45]. Th1 and Th2 cells secrete different cytokines. Th1 
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cells are dependent on IL-2, IFN-γ, and TNF, which are involved in cell-mediated 
immunity against pathogens. Th2 cells are mostly dependent on IL-4 and IL-5, 
which stimulate the production of IgE antibodies and eosinophil responses, result-
ing in allergic diseases [46, 47]. An imbalanced Th1/Th2 immune response is linked 
to certain hypersensitivity disorders such as allergy, asthma, and hay fever [48]; 
therefore, studies have suggested that using BRM to restore the balance between 
Th1 and Th2 immune response could be a treatment option for the IgE-dependent 
hypersensitivity [49]. Ganoderma lucidum is a medicinal mushroom, which has 
been widely used for hundreds of years as a folk medicine in oriental countries such 
as China and Japan for its immunomodulating and antitumour effects. Numerous 
biological available substances with immunity enhancement effects, in particular 
polysaccharides, have been isolated from the extract of G. lucidum [50].
Antimicrobial peptides are effective components of innate immunity that are 
widely present in the biological system. Hepcidin is a 25-amino acid antibiotic 
peptide synthesized in the liver, which is reportedly responsible for regulating iron 
balance and recycling in humans and mice. Studies on 0–100 μg/mL concentrations 
of hepcidin incubated with HT1080, Hep-G2, and HeLa for 24 h revealed higher 
growth inhibition ratios after treatment with 70 μg/mL hepcidin in HT1080 cells. 
Hepcidin was very effective at inhibiting the growth of fibrosarcoma cells [51, 52]. 
Studies on tachyplesin, an antimicrobial peptide present in leukocytes of the horse-
shoe crab (Tachypleus tridentatus), demonstrated that tachyplesin was able to inhibit 
the growth of TSU tumour cells on the chorioallantoic membrane of chicken embryos 
and B16 tumour cells in syngeneic mice. Tachyplesin also blocked the prolifera-
tion of both tumour and endothelial cells in culture in a dose-dependent manner, 
whereas proliferation was relatively unaffected in nontumorigenic cell lines Cos-7 
and NIH-3T3 [53]. D-K4R2L9 is a peptide with 15 amino acid residues, comprising of 
Leu, Lys, and Arg residues, which binds to and lyses B16-F10 mouse melanoma cells 
in culture at concentrations that do not harm normal 3T3 fibroblasts or erythrocytes, 
thereby preventing intravenous-injected D122 lung carcinoma cells from forming 
lung tumours in mice [54, 55]. Another antimicrobial peptide, bovine lactoferricin 
(LfcinB), is a 25-amino acid, highly basic peptide with a disulphide bridge between 
two cysteines; thus, LfcinB is a cyclic twisted antiparallel β-sheet solution structure. 
The effects of LfcinB on neuroblastoma growth were investigated in vivo, which 
revealed that SH-SY-5Y xenografts in nude rats were significantly inhibited after 
injections of 1.0 or 2.0 mg of LfcinB compared with untreated controls [56]. Related 
research has demonstrated that antimicrobial peptides can activate specific innate 
immune responses and lead to immunomodulatory effects in the host when there is 
a risk of damage. Furthermore, the antimicrobial peptides are proposed to modulate 
the host’s immune system through inflammatory responses and stimulate the benefi-
cial aspects of inflammation, including inhibition of tumour growth.
4. Conclusion
Immunotherapy is being developed and presents certain advantages of alterna-
tive medicine because immunomodulation factors, such as mushroom beta-glucan, 
antimicrobial peptides, and triterpenoid, represent a novel therapeutic approach 
for cancer therapy and may provide an alternative to deal with the problem of drug 
resistance. However, exploring current insights into tumour biology and tumour 
micro-environment is complex and involves chemistry, biology, instrumentation, 
and formulation science. Therefore discovering a novel, more effective tumour-
targeting treatment is difficult. Immunotherapy is hypothesized to be an alternative 
therapy that could be applied in the early phase of clinical tumour therapy.
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